Open Access News

News from the open access movement


Friday, March 17, 2006

OA to genome sequences for 11 more mammals

Glyn Moody, The Power of Open Genomics, Open..., March 16, 2006. Excerpt:
The National Human Genome Research Institute (NHGRI), one of the National Institutes of Health (NIH), has announced the latest round of mega genome sequencing projects - effectively the follow-ons to the Human Genome Project. These are designed to provide a sense of genomic context, and to allow all the interesting hidden structures within the human genome to be teased out bioinformatically by comparing them with other genomes that diverged from our ancestors at various distant times.  Three more primates are getting the NHGRI treatment: the rhesus macacque, the marmoset and the orangutan. But alongside these fairly obvious choices, eight more mammals will be sequenced too....If you are not quite sure whom to vote for, you might want to peruse a great page listing all the genomes currently being sequenced for the NHGRI, which provides links to a document...explaining why each is important (there are pix, too).  More seriously, it is worth noting that this growing list makes ever more plain the power of open genomics. Since all of the genomes will be available in public databases as soon as they are completed (and often before), this means that bioinformaticians can start crunching away with them, comparing species with species in various ways. Already, people have done the obvious things like comparing humans with chimpanzees, or mice with rats, but the possibilities are rapidly becoming extremely intriguing....And beyond the simple pairing of genomes, which yields a standard square-law richness, there are even more inventive combinations involving the comparison of multiple genomes that may reveal particular aspects of the Great Digital Tree of Life, since everything may be compared with everything, without restriction. Now imagine trying to do this if genomes had been patented, and groups of them belonged to different companies, all squabbling over their "IP". The case for open genomics is proved, I think.